Evidence map›Paper›PMID 28333978›Full record

ArticlePloS one2017

Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey.

Yang Zhou, Susan van den Hof, Shengfen Wang, Yu Pang, Bing Zhao, Hui Xia, Richard Anthony, Xichao Ou, Qiang Li, Yang Zheng and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Genotypic Characteristics ofChina CDC weekly · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Drug Resistance ofJournal of immunology research · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Resistance ofHeliyon · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Yang ZhouChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Susan van den HofKNCV Tuberculosis Foundation, CC The Hague, The Netherlands.
Shengfen WangChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Yu PangChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Bing ZhaoChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Hui XiaChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Richard AnthonyNational Institute for Public Health and the Environment, the Netherlands,BA Bilthoven, The Netherlands.
Xichao OuChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Qiang LiChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Yang ZhengChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Yuanyuan SongChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Yanlin ZhaoChinese Centre for Disease Control and Prevention, Changping district, Beijing, China, P.R.
Dick van SoolingenNational Institute for Public Health and the Environment, the Netherlands,BA Bilthoven, The Netherlands.
Chinese Center For Disease Control and Prevention · CNNational Institute for Public Health and the Environment · NLTuBerculosis Vaccine Initiative · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p<0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p<0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.

Indexed as

Antitubercular AgentsChinaGenotypeHumansMicrobial Sensitivity TestsMinisatellite RepeatsMycobacterium tuberculosisRifampinStreptomycinSurveys and QuestionnairesTuberculosis, Multidrug-ResistantAntitubercular AgentsRifampinStreptomycin

Identifiers

PMID28333978
PMCPMC5363926
OpenAlexW2598118080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.